Diuretics in Renal Disorders

Intro: Diuretics & Kidneys - Kidney Kickstarters

• Diuretics: Drugs that increase urine output (diuresis) by enhancing renal salt and water excretion.
• Kidney's Central Role: Primary site of action; diuretics modulate specific transport mechanisms along different segments of the nephron.
  • Proximal Convoluted Tubule (PCT)
  • Loop of Henle (LOH)
  • Distal Convoluted Tubule (DCT)
  • Collecting Ducts (CD)
• Goals in Renal Disorders:
  • Manage fluid overload (e.g., edema, hypertension).
  • Correct electrolyte imbalances (e.g., hyperkalemia).
  • Alleviate symptoms of congestion.
• Challenges in Impaired Renal Function (↓ GFR):
  • Reduced drug delivery to tubular sites of action.
  • Potential for diuretic resistance.
  • Higher doses or combination therapy may be required.

⭐ In patients with significant renal impairment (e.g., GFR < 30 mL/min/1.73m²), loop diuretics are generally the most effective class, as thiazide diuretics lose much of their efficacy.

Classes vs. GFR - Filter Fixers

Use in Renal Diseases - Disorder Duty

Diuretic choice hinges on renal function, primarily Glomerular Filtration Rate (GFR).

• Chronic Kidney Disease (CKD):
  • GFR > 30 mL/min: Thiazides (e.g., Hydrochlorothiazide).
  • GFR < 30 mL/min: Loop diuretics (e.g., Furosemide, Torsemide) essential. Higher doses often needed.
  • Resistant edema: Combine Loop + Thiazide (Metolazone).
• Acute Kidney Injury (AKI):
  • Loop diuretics for volume overload if patient is urine-producing.
  • ⚠️ Not for AKI prevention or to hasten recovery.
• Nephrotic Syndrome:
  • Loop diuretics are mainstay for massive edema.
  • High doses often required due to proteinuria & hypoalbuminemia.
  • Combination therapy (Loop + Thiazide/K-sparing) common.

⭐ In advanced CKD (GFR < 30 mL/min), most thiazides (except metolazone) lose efficacy, making loop diuretics the agents of choice.

Risks & Checks - Watchful Waters

• Diuretic Resistance in CKD:
  • Reduced GFR impairs drug delivery to tubules.
  • Compensatory ↑Na+ reabsorption in other nephron segments.
  • Proteinuria (e.g., nephrotic syndrome) binds drug.
  • Management: Higher doses, IV route, loop + thiazide combo.
• Key Adverse Effects (Renal Patients):
  • Volume depletion, orthostatic hypotension.
  • Electrolyte shifts: Hypokalemia (loops/thiazides), ⚠️Hyperkalemia (K+-sparing, esp. with ACEi/ARB in CKD), hyponatremia, hypomagnesemia.
  • Ototoxicity: High-dose IV loop diuretics (esp. ethacrynic acid).
  • Hyperuricemia & gout: Thiazides, loop diuretics.
• Essential Monitoring:
  • Daily weights, strict I/O charting, BP (supine/standing).
  • Serial labs: Serum K+, Na+, Cr, BUN, uric acid, Mg++.
  • Clinical signs of dehydration or fluid overload.

⭐ Loop diuretics are preferred in severe renal impairment (GFR < 30 mL/min) as thiazides become ineffective.

High‑Yield Points - ⚡ Biggest Takeaways

• Thiazides are generally ineffective if GFR < 30 mL/min; metolazone is an exception.
• Loop diuretics (e.g., furosemide) are first-line for managing edema in CKD and nephrotic syndrome.
• Spironolactone can be used in nephrotic syndrome but carries a high risk of hyperkalemia in CKD.
• Mannitol is primarily for reducing ↑ intracranial/intraocular pressure, not for general edema in renal disease.
• Closely monitor electrolytes (especially K+), renal function, and volume status with diuretic use in renal patients.
• Diuretic resistance in advanced CKD may necessitate combination therapy (e.g., loop + thiazide) or increased doses.